gaurav bhende

Executive Summary The Global Diabetes Devices Market is poised for significant growth over the next decade, projected to expand from USD 15.25 billion in 2022 to approximately USD 29.41 billion by 2031. This trajectory reflects a compound annual growth rate (CAGR) of 7.45% between 2024 and 2031. The market’s expansion is being fueled by several converging forces: the accelerating prevalence of diabetes worldwide, especially in low- and middle-income countries; the increasing adoption of digital and connected health technologies; and growing investments in innovative solutions that simplify diabetes management. Technologies like Continuous Glucose Monitoring (CGM), wearable insulin pumps, and artificial pancreas systems are revolutionizing how patients manage their condition. Combined with AI-based diabetes management software and the shift toward personalized, home-based care, these advancements are creating an ecosystem designed to empower patients and reduce the burden of diabet...

  The global diabetes devices market , estimated at USD 15.25 billion in 2022, is set to more than double by 2031, reaching an anticipated value of USD 29.41 billion. The market is forecast to expand at a compound annual growth rate (CAGR) of 7.45% during the forecast period 2024–2031. The period from 2019 to 2023 also witnessed a steady CAGR, driven by increasing awareness, healthcare investments, and growing adoption of advanced glucose monitoring and insulin delivery systems. However, this growth was significantly influenced by macroeconomic shifts due to the COVID-19 pandemic and the Russia-Ukraine conflict. Market Overview Diabetes devices play a vital role in the daily management of blood glucose levels and insulin administration. As diabetes prevalence continues to rise globally—fueled by sedentary lifestyles, aging populations, and dietary habits—the demand for convenient, accurate, and real-time monitoring devices is intensifying. The market encompasses a broad range o...